Susquehanna International Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,900
| Closed | -$16.4K | – | 13746 |
|
|
2023
Q3 | $16.4K | Buy |
+12,900
| New | +$11.3K | ﹤0.01% | 11648 |
|
|
2022
Q1 | – | Sell |
-92,700
| Closed | -$267K | – | 14296 |
|
|
2021
Q4 | $267K | Sell |
92,700
-24,700
| -21% | -$91.4K | ﹤0.01% | 10767 |
|
|
2021
Q3 | $498K | Sell |
117,400
-101,700
| -46% | -$454K | ﹤0.01% | 9416 |
|
|
2021
Q2 | $1.16M | Sell |
219,100
-161,000
| -42% | -$774K | ﹤0.01% | 7355 |
|
|
2021
Q1 | $1.77M | Buy |
380,100
+197,300
| +108% | +$894K | ﹤0.01% | 6227 |
|
|
2020
Q4 | $603K | Buy |
182,800
+10,600
| +6% | +$40.3K | ﹤0.01% | 7878 |
|
|
2020
Q3 | $570K | Sell |
172,200
-89,500
| -34% | -$329K | ﹤0.01% | 7405 |
|
|
2020
Q2 | $882K | Sell |
261,700
-89,100
| -25% | -$421K | ﹤0.01% | 6200 |
|
|
2020
Q1 | $1.34M | Sell |
350,800
-98,300
| -22% | -$457K | ﹤0.01% | 4717 |
|
|
2019
Q4 | $2.71M | Buy |
449,100
+137,600
| +44% | +$941K | ﹤0.01% | 3853 |
|
|
2019
Q3 | $2.35M | Sell |
311,500
-226,400
| -42% | -$2.55M | ﹤0.01% | 3888 |
|
|
2019
Q2 | $7.29M | Buy |
537,900
+343,200
| +176% | +$3.96M | ﹤0.01% | 2248 |
|
|
2019
Q1 | $1.05M | Buy |
194,700
+6,400
| +3% | +$31.1K | ﹤0.01% | 4940 |
|
|
2018
Q4 | $559K | Sell |
188,300
-98,500
| -34% | -$539K | ﹤0.01% | 5806 |
|
|
2018
Q3 | $2.34M | Buy |
286,800
+137,100
| +92% | +$1.05M | ﹤0.01% | 3749 |
|
|
2018
Q2 | $1.46M | Buy |
149,700
+35,800
| +31% | +$367K | ﹤0.01% | 4595 |
|
|
2018
Q1 | $990K | Sell |
113,900
-26,600
| -19% | -$287K | ﹤0.01% | 5260 |
|
|
2017
Q4 | $1.76M | Sell |
140,500
-73,700
| -34% | -$845K | ﹤0.01% | 4144 |
|
|
2017
Q3 | $1.79M | Sell |
214,200
-143,400
| -40% | -$1.52M | ﹤0.01% | 4117 |
|
|
2017
Q2 | $6.07M | Buy |
357,600
+329,100
| +1,155% | +$6.54M | ﹤0.01% | 2179 |
|
|
2017
Q1 | $573K | Buy |
+28,500
| New | +$566K | ﹤0.01% | 6245 |
|
Susquehanna International Group's ZYNE Position: Q4 2023 in Review
Susquehanna International Group sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 221,719 shares — an estimated $282K sold.
Susquehanna International Group first reported a position in ZYNE in Q4 2017 and held it in 18 quarters. The position peaked at $2.69M in Q3 2018. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.
- Susquehanna International Group reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
- Susquehanna International Group sold 221,719 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $282K.
- Susquehanna International Group first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2017 and held it in 18 quarters.
- Susquehanna International Group's Zynerba Pharmaceuticals, Inc position peaked at $2.69M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.